EFNA1 and cancer: Miao et al. showed that EphA2 is a substrate and effector of PI3 kinase/Akt signaling through phosphorylation of serine 897 in the EphA2 cytoplasmic domain, a pathway by which EphA2 controls cancer cell motility and invasion independently of ephrin-A1 [9, 10].